{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:44:12Z","timestamp":1782996252410,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:00:00Z","timestamp":1236729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10067-009-1154-7","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T04:23:44Z","timestamp":1236659024000},"page":"53-55","source":"Crossref","is-referenced-by-count":26,"title":["Guillain\u2013Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy"],"prefix":"10.1007","volume":"28","author":[{"given":"Amine","family":"Bouchra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Benbouazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najia","family":"Hajjaj-Hassouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1445-5994.2007.01601.x","volume":"38","author":"SL James","year":"2008","unstructured":"James SL, Irving PM, Gearry RB, Gibson PR (2008) Management of distal ulcerative colitis: frequently asked questions analysis. Intern Med J 38:114\u2013119","journal-title":"Intern Med J"},{"key":"1154_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3346\/jkms.1998.13.1.39","volume":"13","author":"S Chang-Hee","year":"1998","unstructured":"Chang-Hee S, Chang-Hee L et al (1998) Arthritis manifestations of inflammatory bowel disease. J Korean Med Sci 13:39\u201343","journal-title":"J Korean Med Sci"},{"key":"1154_CR3","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keh205","volume":"43","author":"J Braunand","year":"2004","unstructured":"Braunand J, Sieper J (2004) Biological therapies in the spondyloarthritides\u2014the current state. Rheumatology 43:1072\u20131084","journal-title":"Rheumatology"},{"issue":"4","key":"1154_CR4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/brain\/awh429","volume":"128","author":"FAA Gondim","year":"2005","unstructured":"Gondim FAA, Brannagan TH, Sander HW, Chin RL, Latov N (2005) Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128(4):867\u2013879","journal-title":"Brain"},{"issue":"8","key":"1154_CR5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2169\/internalmedicine.32.651","volume":"32","author":"R Okiyama","year":"1993","unstructured":"Okiyama R, Yamada M, Tamaki M, Orimo S, Arai M (1993) Mononeuropathy multiplex with ulcerative colitis. Intern Med 32(8):651\u2013654","journal-title":"Intern Med"},{"issue":"1","key":"1154_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/bega.2002.0345","volume":"17","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ (2003) Strategies for targeting tumour necrosis factor in IBD. Best Pract Res Clin Gastroenterol 17(1):105\u2013117","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"1154_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2169\/internalmedicine1962.28.72","volume":"28","author":"Y Konagaya","year":"1989","unstructured":"Konagaya Y, Konagaya M, Takayanagi T (1989) Chronic polyneuropathy and ulcerative colitis. Jpn J Med 28(1):72\u201374","journal-title":"Jpn J Med"},{"key":"1154_CR8","first-page":"575","volume":"67","author":"S Silburn","year":"2008","unstructured":"Silburn S, McIvor E, Mc Entegart A, Wilson H (2008) Guillain\u2013Barr\u00e9 syndrome in a patient receiving anti-tumour necrosis factor \u03b1 for rheumatoid arthritis: a case report and discussion of literature. ARD 67:575\u2013576","journal-title":"ARD"},{"issue":"3","key":"1154_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","volume":"37","author":"J-P St\u00fcbgen","year":"2008","unstructured":"St\u00fcbgen J-P (2008) Tumor necrosis factor-\u03b1 antagonists and neuropathy. Muscle Nerve 37(3):281\u2013292","journal-title":"Muscle Nerve"},{"issue":"5","key":"1154_CR10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","volume":"54","author":"I-SJ Shin","year":"2006","unstructured":"Shin I-SJ, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain\u2013Barre and Miller Fisher syndromes occurring with tumor necrosis factor \u03b1 antagonist therapy. Arthritis Rheum 54(5):1429\u20131434","journal-title":"Arthritis Rheum"},{"key":"1154_CR11","first-page":"645","volume":"64","author":"N Neven","year":"2005","unstructured":"Neven N, Vis M, Voskuyl AE, Wolbink GJ, Nurmohamed MT, Dijkmans BAC, Lems WF (2005) Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice. ARD 64:645\u2013646","journal-title":"ARD"},{"key":"1154_CR12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/01.wnl.0000277697.55288.d0","volume":"69","author":"M Slee","year":"2007","unstructured":"Slee M, Selan A, Donaghy M (2007) Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 69:1680\u20131687","journal-title":"Neurology"},{"key":"1154_CR13","first-page":"1018","volume":"33","author":"J Jarand","year":"2006","unstructured":"Jarand J, Zochodne DW, Martin L, Voll C (2006) Neurological complications of infliximab. J Rheumatol 33:1018\u20131020","journal-title":"J Rheumatol"},{"issue":"10","key":"1154_CR14","first-page":"2079","volume":"31","author":"P Richette","year":"2004","unstructured":"Richette P, Dieud\u00e9 P, Damiano J (2004) Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 31(10):2079\u20132081","journal-title":"J Rheumatol"},{"key":"1154_CR15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/rheumatology\/keh439","volume":"44","author":"C Rodriguez-Escalera","year":"2005","unstructured":"Rodriguez-Escalera C, Belzunegui J (2005) Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology 44:132\u2013133","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1154-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1154-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1154-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:35Z","timestamp":1559105495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1154-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":15,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1154-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]}}}